| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-12 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |